Humalog kwikpen and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Humalog kwikpen (insulin lispro recombinant), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humalog, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Memory loss when taking Humalog kwikpen. It is created by eHealthMe based on reports of 3,425 people who have side effects when taking Humalog kwikpen from the FDA, and is updated regularly.

What is Humalog kwikpen?

Humalog kwikpen has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 3,512 Humalog kwikpen users. Check the latest studies of Humalog kwikpen.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jul, 17, 2026

3,425 people reported to have side effects when taking Humalog kwikpen.
Among them, 81 people (2.36%) have Memory loss.

Could Humalog kwikpen cause Memory loss?

Among these 81 people:

How long have people been on Humalog kwikpen when they have Memory loss? *

What is the gender of people who have Memory loss when taking Humalog kwikpen? *

female: 59.26 %
male: 40.74 %

What is the age of people who have Memory loss when taking Humalog kwikpen? *

What are other drugs people take besides Humalog kwikpen? *

What are other side effects people have besides Memory loss? *

Blood Glucose Increased: 22 people, 27.16%
Blood Glucose Decreased: 13 people, 16.05%
Visual Impairment: 12 people, 14.81%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 10 people, 12.35%
Cataract (clouding of the lens inside the eye): 9 people, 11.11%
Hypoacusis (loss of hearing): 8 people, 9.88%
Headache (pain in head): 7 people, 8.64%
Confusional State: 6 people, 7.41%
Blood Glucose Abnormal: 5 people, 6.17%
Fall: 4 people, 4.94%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.70%
High Blood Pressure: 2 people, 2.47%
Depression: 2 people, 2.47%
Headache (pain in head): 1 person, 1.23%
Bladder Spasm: 1 person, 1.23%
Blood Glucose Increased: 1 person, 1.23%
Blood Pressure Abnormal: 1 person, 1.23%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 1.23%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 1.23%
Constipation: 1 person, 1.23%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog kwikpen and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humalog kwikpen:

Humalog kwikpen (3,512 reports)

Memory loss treatments and more:

Memory loss (244,444 reports)

Browse all side effects of Humalog kwikpen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,728 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,375 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant (the active ingredients of Humalog kwikpen) and Humalog kwikpen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.